Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Conferences | Events

Quotient Bioresearch and KWS BioTest partner to deliver end-to-end anti-infectives screening

Quotient BioresearchLeading drug development service providers, Quotient Bioresearch Ltd. and KWS BioTest Ltd., have today announced a new strategic partnership to provide a novel co-ordinated approach to support the discovery and development of new antimicrobial agents.

The partnership - unveiled at the 21st European Congress of Clinical Microbiology and Infectious Diseases 2011 (ECCMID 2011) in Milan, Italy - will enable the two companies to provide high quality screening of anti-infectives all the way from in vitro activity assays, efficacy and resistance profiling through validated models of human disease to surveillance and clinical investigations, with full scientific support.

Dr. Ian Morrissey, Director of Anti-Infectives at Quotient, explained: "With KWS we can provide a unique and fully-integrated ‘Plate to Patient' offering for our anti-infective clients, by now including anti-virals and models of human disease."

The new partnership has been created following a longstanding relationship between Quotient and KWS and represents significant expansion in the industry for both companies. Sharing a number of joint customers, the synergy created through this collaboration will enable both companies to carry out larger integrated studies with associated added value and efficiencies for their clients. 

Prof. Neil Williams, Director of Science at KWS BioTest, is excited to formalise an agreement with Quotient. He commented: "Both companies have established themselves on a basis of providing a high quality of service, scientific understanding and support to their clients."

Ian Morrissey and Leann Quinn (Associate Director, Business Development at KWS) will be available for discussions at the 21st ECCMID conference, where Ian will also be holding a presentation at 16:00 on Monday, May 9 on Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe (2007-2008). In addition, Quotient is showcasing its latest suite of posters at its booth, number 629. 

For further information about Quotient Bioresearch Ltd., visit the website at www.quotientbioresearch.com/bioanalytical-sciences.  Further information about KWS BioTest Ltd. can be found at www.kwsbiotest.co.uk.


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

Today's Picks

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners